Pnc Financial Services Group, Inc. Cel Sci Corp Transaction History

Pnc Financial Services Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$7.64 - $12.49 $68 - $112	-9 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$12.0 - $27.64 $108 - $248	9 New	9 $0
Q4 2019 Feb 07, 2020	SELL	$6.71 - $9.55 $1,342 - $1,910	-200 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$6.0 - $9.6 $1,194 - $1,910	199 Added 19900.0%	200 $1,000
Q2 2019 Aug 09, 2019	BUY	$3.77 - $8.67 $3 - $8	1 New	1 $0

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $27.8M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.